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Calmodulin-dependent protein phosphatase from bo­
vine brain and heart was assayed for phosphotyrosine 
and phosphoserine phosphatase activity using several 
substrates: 1) smooth muscle myosin light chain (LC20) 
phosphorylated on tyrosine or serine residues, 2) an­
giotensin I phosphorylated on tyrosine, and 3) syn­
thetic phosphotyrosine- or phosphoserine-containing 
peptides with amino acid sequences patterned after the 
autophosphorylation site in Type II regulatory subunit 
of the cAMP-dependent protein kinase. The phospha­
tase was activated by N i2+ and Mn2+, and stimulated 
further by calmodulin. In the presence of Nia+ and 
calmodulin, it exhibited similar kinetic constants for 
the dephosphorylation of phosphotyrosyl LC20 (Km = 
0.9 (iM, and = 350 nmol/min/mg) and phosphoseryl 
LC20 (Km = 2 .6  /iM, Vmax = 690 nmol/min/mg). Dephos­
phorylation of phosphotyrosyl LC20 was inhibited by 
phosphoseryl LC20 with an apparent K, of 2 nM. Com­
pared to the reactions with phosphotyrosyl LC2o as the 
substrate, reactions with phosphotyrosine-containing 
oligopeptides exhibited slightly higher K m and lower 
Vmax values. The reaction with the phosphoseryl pep­
tide based on the Type II regulatory subunit sequence 
exhibited a slightly higher K m (23 / im ) , but a much 
higher Vmax (4400 nmol/min/mg) than that with its 
phosphotyrosine-containing counterpart. Micromolar 
concentrations of Zn2+ inhibited the phosphatase activ­
ity; vanadate was less potent, and 25  mM NaF was 
ineffective. The study provides quantitative data to 
serve as a basis for comparing the ability o f the cal­
modulin-dependent protein phosphatase to act on phos­
photyrosine- and phosphoserine-containing substrates.
The calmodulin-dependent protein phosphatase, also 
known as calcineurin, was originally purified as a major 
calcium- and calmodulin-binding protein from bovine brain 
(1, 2). Subsequent investigations indicated that this protein 
was identical to a calmodulin-dependent protein phosphatase 
(designated protein phosphatase 2B) purified from rabbit 
skeletal muscle (3, 4). Based on immunological and immuno- 
histochemical data (5, 6), it is known that this enzyme is 
located predominantly in the brain but also in a variety of 
other mammalian tissues. Purification of the phosphatase 
from bovine brain (1, 2, 7), rabbit skeletal muscle (3, 8), 
bovine heart (9, 10), and most recently human platelets (11)
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has been reported. The enzyme is found to consist of two 
subunits having different molecular weights. Subunit A (M, 
~ 61,000) interacts with calmodulin and contains the catalytic 
site (12-15); subunit B (Mt ~  15,000) binds up to four Ca2+ 
with high affinity (13,15).
Physiological substrates for the calmodulin-dependent pro­
tein phosphatase have not been established. Under in vitro 
conditions, the enzyme catalyzes the dephosphorylation of a 
variety of proteins phosphorylated at serine or threonine 
residues (4, 8, 14-19), but exhibits a high catalytic efficiency 
toward only a few of these phosphoproteins. This enzyme is 
thus considered to have a very narrow substrate specificity 
compared to other known protein phosphatases (17, 20). 
Recent reports have indicated that the calmodulin-dependent 
protein phosphatase also exhibits activity toward free phos­
photyrosine and p-nitrophenyl phosphate (2 1 , 22), phospho­
tyrosyl casein (23), and the epidermal growth factor receptor 
(24), but detailed comparisons of phosphotyrosyl and phos­
phoseryl dephosphorylation reactions have not been per­
formed under comparable conditions. The question is still 
open, therefore, of whether the calmodulin-dependent phos­
phatase exhibits kinetic characteristics suggesting that it 
might be capable of catalyzing the dephosphorylation of phos­
photyrosyl and phosphoseryl/threonyl proteins in vivo.
In the present report, we present a detailed characterization 
and comparison of the phosphoseryl and phosphotyrosyl 
phosphatase activities of the calmodulin-dependent phospha­
tase using defined substrates. All of the protein and peptide 
substrates used were of known sequence and contained phos­
phoserine or phosphotyrosine residues at characterized sites. 
Moreover, in one instance, peptide substrates were con­
structed so that phosphoserine or phosphotyrosine was pres­
ent in an identical peptide sequence. Kinetic constants ob­
tained for the reactions with different substrates were used as 
a basis for comparisons. In light of evidence (25) indicating 
that the phosphatase exists in at least two main isozymic 
species (neuronal and non-neuronal), the experiments were 
performed using preparations of enzyme purified from bovine 
brain and cardiac muscle. In addition, activation by divalent 
cations (Ni2+ and Mnz+) in the presence of calmodulin, and 
the inhibition by various common phosphatase inhibitors (F~, 
Zn2+, and VOf") of both phosphoseryl and phosphotyrosyl 
phosphatase activities of the enzyme were investigated. The 
results of these studies indicate that the calmodulin-depend­
ent phosphatase can, under certain conditions, catalyze the 
dephosphorylation of phosphotyrosyl substrates at rates com­
parable to those seen with phosphoseryl substrates.
EXPERIMENTAL PROCEDURES
Materials—Epidermal growth factor was purchased from Collabo­

























ATP was obtained from Du Pont/New England Nuclear. All other 
chemicals were of reagent grade. The Rn1 peptides, Rh-(81-99)- 
peptide and [Tyr95]Rn-(81-99)-peptide, were prepared using a Beck­
man 990 automated peptide synthesizer and standard solid-phase 
techniques (19) and subsequently purified by reversed-phase high- 
performance liquid chromatography. Human epidermoid carcinoma 
A431 cells were subcultured and membranes prepared according to 
Brautigan et al. (26).
Preparation of Proteins—Calmodulin-dependent protein phospha­
tase was purified from bovine brain according to the procedure 
described by Sharma et al. (7) and from bovine cardiac muscle by a 
modified procedure described elsewhere (19). Calmodulin was purified 
from fresh and frozen bovine testes (27). Smooth muscle regulatory 
myosin light chain (LC20) was purified from chicken gizzard as 
previously described (28). Smooth muscle myosin light chain kinase 
was purified from chicken gizzard (29), and the catalytic subunit of 
cAMP-dependent protein kinase was purified from bovine heart (30) 
according to published procedures. Monoclonal antibody against the 
B subunit of the brain calmodulin-dependent protein phosphatase 
(VAi) was obtained from mouse as described elsewhere (31).
Preparation of Phosphorylated Substrates—LC20 was phosphoryl- 
ated at two tyrosine sites (tyrosine 142 and 155) using an A431 cell 
membrane preparation as previously described (28). The 90-m1 reac­
tion mixture contained 4 jag of A431 membranes, 100 ng of epidermal 
growth factor, 0.1% Nonidet P-40, 2.5 mM MnCl2, 30 mM HEPES, 
pH 7.4, 100 uM sodium orthovanadate, 600 mM [7 -32P]ATP (specific 
activity 800-1200 cpm/pmol) and 10 mM LC20. Protein-bound radio­
activity throughout the course of the phosphorylation reaction was 
followed using a filter paper technique as previously described (28). 
Stoichiometry of phosphate incorporation was calculated based on 
the specific activity of the radioisotope, the amount of protein-bound 
radioactivity, and the amount of substrate added to the reaction. 
After 120 min at 30 °C, the reaction mixture was subjected to electro­
dialysis against 2 mM MOPS, pH 7.0, 1 mM dithiothreitol, and 0.1 M 
urea to remove unincorporated 32P. The resultant mixture was then 
equilibrated with 25 mM MOPS, pH 7.0, 1 mM dithiothreitol, and 0.3 
M NaCl by extensive dialysis. The [32P]phosphotyrosyl LC20 used in 
dephosphorylation experiments was estimaed to contain 1.5-2.0 mol 
of 32P/mol of protein.
Smooth muscle LC2o was also phosphorylated at a serine residue 
(serine 19) in a separate reaction using smooth muscle myosin light 
chain kinase as described (25, 32). The phosphorylation reaction was 
carried out in 50 mM MOPS, pH 7.0,0.2 mM CaCl2, 10 mM magnesium 
acetate, 1 fiM calmodulin, 1 mM dithiothreitol, 1 mM [ t - I2P]ATP 
(specific activity 400-500 cpm/pmol), 2 fig/ml myosin light chain 
kinase, and 10 /iM LC20 at 30 °C for 120 min. Excess [7 -32P]ATP was 
removed as described above. The [32P]phosphoseryl LC20 was esti­
mated to contain 1  mol of 32P/mol of protein.
Angiotensin I and [Tyr95]Rn-(81-99)-peptide peptides were phos­
phorylated at their respective tyrosine residues using A431 cell mem­
branes as described for phosphotyrosyl LC20 above. Phosphopeptides 
were separated from non-peptide-bound 32P by chromatography on 
AG 1-X2 acetate (Bio-Rad) columns using 1 n  acetic acid. After 
evaporation under reduced pressure, the phosphopeptides were resus­
pended in water, and the solutions were adjusted to neutral pH. 
Phosphate incorporation, as indicated by the filter paper assay, was 
found to be approximately 0.2 mol of 32P/mol of peptide. This neces­
sitated further purification since most of the peptides in the mixtures 
were in the unphosphorylated forms, which might cause product 
inhibition in the subsequent dephosphorylation reactions. The phos­
phorylated and unphosphorylated forms were separated by reversed- 
phase high-performance liquid chromatography using a gradient of 
acetonitrile in the presence of trifluoroacetic acid. Fractions were 
pooled according to radioactivity and concentrated by evaporation 
under reduced pressure. The stoichiometry of phosphorylation was 
estimated to be greater than 0.8 mol of 32P/mol of peptide.
Rn-(81-99)-peptide was phosphorylated at its serine residue using
1 The abbreviations used are: Rn, type II regulatory subunit of 
cAMP-dependent protein kinase; LC20, the 20,000-dalton myosin 
regulatory light chain from chicken gizzard; Rn-(81-99)-peptide, a 
synthetic peptide having the sequence corresponding to residues 81­
99 of Ru; [Tyr96]Rn-(81-99)-peptide, Rn-(81-99) peptide having a 
tyrosine substituted for residue 95; VAi, monoclonal antibody against 
B subunit of brain calmodulin-dependent protein phosphatase; 
HEPES, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; MOPS,
4-morpholinepropanesulfonic acid.
bovine cardiac cAMP-dependent protein kinase catalytic subunit in 
a reaction containing 50 mM MOPS, pH 7.0, 5 mM magnesium 
acetate, 1 mM dithiothreitol, 2 mM [7 -**P]ATP (specific activity 200­
400 cpm/pmol), 0.028 mg/ml catalytic subunit, and 1 mM peptide, at 
30 °C for 120 min. The stoichiometry was determined to be 1  mol of 
32P/mol of peptide. Non-peptide-bound 32P was removed as described 
for the phosphotyrosyl peptides above.
Dephosphorylation Asssay—Calmodulin-dependent protein phos­
phatase (brain or heart enzyme) was routinely preincubated for 4 min 
at 30 °C at a concentration of 0 .11  mg/ml in the presence of 0.1 mg/ 
ml bovine serum albumin, 1 mM divalent metal cation (as indicated), 
and 50 mM MOPS, pH 7.0, before subsequent addition to the de­
phosphorylation reaction mixtures. Phosphatase activity was assayed 
at 30 °C in 50 mM MOPS, pH 7.0,1 mM dithiothreitol, 1 fiM calmod­
ulin, 1 mM divalent metal ion, and varying amounts of phosphorylated 
substrates in a total volume of 40-80 fi\. The enzyme concentration 
in each reaction was adjusted (0.3-0.56 ^g/ml) so that reaction rates 
remained linear for 3-5 min, and substrate depletion never exceeded 
10%. Total 32P in the substrates was determined by directly counting 
a 10-^1 aliquot of the substrate preparation. Background 32P released 
was determined by incubating substrates under identical reaction 
conditions without added phosphatase. To terminate the reactions 
with phosphoprotein substrates, a 20-^1 aliquot of the incubation 
mixture was added to 125-jil of ice-cold 10% trichloroacetic acid. 
Bovine serum albumin was immediately added to a final concentra­
tion of 0.5 mg/ml to facilitate precipitation. Radioactivity in the 
trichloroacetic acid supernatant was then determined in Aquasol (Du 
Pont/New England Nuclear) by liquid scintillation counting. Back­
ground radioactivity was less than 5% of total radioactivity. To 
terminate reactions with phosphopeptide substrates, an aliquot of the 
reaction mixture was added to 0.5 ml of 5% trichloroacetic acid, 0.1 
M potassium phosphate and set on ice. 32Pi released was separated 
from phosphopeptides using AG-50W-X2 (Bio-Rad) resin as outlined 
by Manalan and Klee (16). Eluents were collected and radioactivity 
quantitated by liquid scintillation counting. Background radioactivity 
was less than 1% of total radioactivity. Units of activity are expressed 
in terms of nanomoles of 32Pi released per minute per milligram of 
protein.
For experiments with inhibitors, the compounds were first prein­
cubated at varying concentrations with the phosphatase and 1 mM 
divalent cation as described above. The same inhibitor concentrations 
were then maintained in the subsequent assays. For reactions with 
phosphotyrosyl peptide substrates, the phosphorylated peptides were 
only purified up to the step before high-performance liquid chroma­
tography (see above, “Preparation of Substrates”); the substrate 
mixture thus contained unphosphorylated peptides. For experiments 
with the monoclonal antibody VAi, the phosphatase was first prein­
cubated with 1 mM Ni2+ and 0.2 mg/ml bovine serum albumin for 4 
min at 30 °C before addition of the antibody at a ratio of 1:2 (en- 
zyme:antibody, w/w) to the mixture. After a further incubation of 5 
min, aliquots were transferred and assayed for phosphatase activity 
as outlined above.
Other Methods—Protein concentrations were determined accord­
ing to Bradford (33), using bovine serum albumin as standard. Spe­
cific activity of [y-32P]ATP used in phosphorylation reactions was 
estimated after dilution of stock [7 -32P]ATP (specific activity = 2500 
Ci/mmol) with nonradioactive ATP. Total radioactivity was deter­
mined by liquid scintillation counting. The concentration of ATP 
was measured enzymatically using the method of Lamprecht and 
Trautschold (34).
RESULTS
Activators of Phosphatase Activity: Nickel, Manganese, and 
Calmodulin—The calmodulin-dependent protein phosphatase 
showed low phosphotyrosyl and phosphoseryl phosphatase 
activities in the presence of 5 m M  EDTA, without added 
activators (data not shown). Short periods of preincubation 
with divalent cations stimulated enzyme activity, as has been 
shown in previous reports (21, 22, 35). Specifically, the de­
phosphorylation of both phosphotyrosyl substrates (phospho­
tyrosyl LC2o and angiotensin) and phosphoseryl substrates 
(phosphoseryl LC20 and Rn-(81-99)-peptide) were found to be 
stimulated by preincubating the enzyme with 1 m M  Ni2+ or 1 
























increase) by 4 min at 30 °C, and remained constant for at 
least 30 min. Activation by Mn2+ was very slight (15% in­
crease) over a 30-min period. Preincubation with either action 
resulted in maximal activation of phosphatase activity at a 
concentration of 1 m M , but was inhibitory at 10 m M . Calmod­
ulin dependence of the enzyme could be demonstrated with 
both phosphotyrosyl and phosphoseryl substrates. In the pres­
ence of 1 mM  Ni2+ or Mn2+, 1 nM calmodulin caused a further 
2-3-fold activation of the enzyme; addition of 100 mm trifluo­
perazine completely inhibited this stimulation (data not 
shown). Based on these results, a standard phosphatase assay 
protocol was established (see “Experimental Procedures”). 
The enzyme was routinely preincubated with 1 mM divalent 
cation and 1 nM calmodulin for 4 min at 30 °C. In the 
subsequent phosphatase assays, these same concentrations of 
activators were maintained. These experimental conditions 
were chosen so that the enzyme could be studied in its 
maximally activated state. It should be emphasized, however, 
that although strong activation is achieved by heavy metals 
in vitro, it is still open as to whether or not they have a 
physiological role.
Inhibitors of Phosphatase Activity: Zinc, Vanadate, Fluoride, 
and Antibody VAi—Three commonly used phosphatase inhib­
itors were tested for their ability to inhibit the dephosphoryl­
ation of phosphotyrosyl and phosphoseryl substrates by the 
calmodulin-dependent protein phosphatase. Zinc ion, at mi­
cromolar concentrations, has been reported to inhibit a phos­
photyrosyl protein phosphatase from Ehrlich ascites tumor 
cells (36). Vandate ion is known to inhibit a variety of enzy­
matic reactions involving phosphate transfer (37), but has 
also been reported to be a specific phosphotyrosyl protein 
phosphatase inhibitor. Swarup et al. (38) reported that 10 /uM 
vanadate caused over 80% inhibition of a phosphotyrosyl 
protein phosphatase activity, whereas phosphoseryl protein 
phosphatase activity was not affected. Fluoride is a widely 
recognized inhibitor of phosphoseryl protein phosphatases, 
but has also been reported to have a slight stimulatory effect 
on phosphotyrosyl protein phosphatases (26). In the present 
study, the inhibitors were added to both the preincubation 
and assay mixtures. As shown in Fig. 1A, Zn2+ inhibited the
Ni2+ and calmodulin-stimulated phosphatase activity at mi­
cromolar concentrations. Fifty per cent inhibition was ob­
served at 3-5 ^M Zn2+ with phosphotyrosyl substrates, and at
9-14 mm Zn2+ with phosphoseryl substrates. Zinc ion also 
inhibited the Mn2+- and calmodulin-stimulated phosphatase 
activity (data not shown). Ten micromolar Zn2+ inibited the 
dephosphorylation of the two phosphotyrosyl substrates by 
75%, and inhibited the dephosphorylation of the two phos­
phoseryl substrates by 60%. In contrast, vanadate was much 
less effective than Zn2+ in inhibiting the Ni2+- and calmodulin- 
stimulated phosphatase activity (Fig. IB). Fifty per cent in­
hibition was observed at concentrations of 500-800 jtM with 
most substrates tested. However, vanadate appeared to be 
more effective when Mn2+ was the activator compared to Ni2+. 
One millimolar vanadate inhibited the Mn2+- and calmodulin- 
stimulated phosphatase activity toward all four substrates 
used in Fig. 1 by 75-80% (data not shown). These results are 
quite different from that of Swarup et al. (38). However, we 
have used purified enzyme and substrate preparations in the 
present study, whereas the above cited investigation dealt 
with a partially purified phosphatase preparation from A431 
cell membranes. Sodium fluoride, at a concentration of 25 
mM, was not inhibitory nor stimulatory toward either the 
Ni2+/calmodulin or the Mn2+/calmodulin-activated enzyme 
(data not shown). We conclude from these results that Zn2+ 
is a more effective inhibitor of the calmodulin-dependent 
protein phosphatase than vanadate, but neither compound is 
a specific inhibitor for phosphotyrosyl protein phosphatases.
A monoclonal antibody developed against the B subunit of 
the brain calmodulin-dependent protein phosphatase (31), 
and designated VAi, caused similar inhibition of the phospho­
tyrosyl and phosphoseryl phosphatase activities. When tested 
at a single concentration against the Ni2+/calmodulin-acti- 
vated brain enzyme, VAi caused a 50% inhibition of the 
dephosphorylation of phosphotyrosyl LC2o and a 40% inhibi­
tion of the dephosphorylation of phosphoseryl Rn-(81-99)- 
peptide (data not shown).
Kinetic Parameters—Table I summarizes the kinetic con-
T able I
Kinetic parameters of dephosphorylation for phosphotyrosyl and
phosphoseryl substrates by brain calmodulin-dependent protein 
phosphatase
Rates of dephosphorylation were determined in the presence of 1 
uM calmodlin and 1 mM of either Ni2+ or Mns+ as described under 
“Experimental Procedures.” The ranges of substrate concentrations 
were 0.3-15 fiM for LC2o, 0.8-14 /xU for [Tyr95]Rlr (81-99)-peptide, 3­
86 jzM for angiotensin I, and 3-140 uM for Rn-(81-99)-peptide. En­
zyme concentrations (0.03-14 ng/ml) were adjusted so that the reac­
tion rates remained linear for 3-5 min. The Km and Vm„  for each 
substrate were determined from direct linear plot (39) of the free 32P 
release data. The values shown are means of two to three separate 
determinations from a single batch of enzyme preparation. For each 
of these means, S.E. value was less than 10% of the mean.
Fig. 1. The effects o f increasing concentrations of (A) zinc 
and (B) vanadate ions on the ac tiv ity  of b ra in  calmodulin- 
dependent pro tein  phosphatase. Dephosphorylation of phospho­
tyrosyl LC20 (0.8 fiM, A), phosphoseryl LC20 (0.8 mm, A), phosphoty­
rosyl [Tyr95]Rir(81-99)-peptide (1 uM, • ) ,  and phosphoseryl Rn-(81- 
99)-peptide (11 O) were measured in the presence of 1 mM Ni2+ 
and 1 nU calmodulin as described under “Experimental Procedures.” 
The inhibitors were present in both the 4-min preincubation and 5- 
min assay periods at the indicated concentrations. 32P released in the 
















LC20 0.9 350 388.9 5.3 10 1.9
[Tyr95]Rn-(81-99)-peptide 2.5 250 100.0 3.0 7 2.3
Angiotensin 1 6.1 274 44.9 26.0 12 0.5
2) Phosphoseryl substrates
LC20 2.6 690 265.4 9.2 360 39.1
























stants for the dephosphorylation of phosphotyrosyl and phos­
phoseryl substrates by the brain calmodulin-dependent pro­
tein phosphatase. In general, the enzyme exhibited lower Km 
values with phosphotyrosyl substrates and exhibited higher 
Vm** values with the phosphoseryl substrates. Phosphotyrosyl 
LC2o appeared to be the best phosphotyrosine-containing 
substrate tested in the present study; the Km was lower and 
the Vmai higher than for the small phosphotyrosyl peptides. 
As LC20 can be phosphorylated on two tyrosine sites, and 
since we have not characterized the dephosphorylation reac­
tion with respect to individual sites, the kinetic constants 
reported here represent a composite rate of dephosphorylation 
of the two sites. For the Ni2+/calmodulin-activated enzyme, 
phosphotyrosyl LC2o was a more favorable substrate than 
phosphoseryl LC20, as indicated by the higher Vma J K m ratio. 
However, the trend was reversed with the two synthetic 
peptides based on the sequence of Rn. Under identical exper­
imental conditions, phosphoseryl Rn-(81-99)-peptide was a 
better substrate than phosphotyrosyl [Tyr9fj]Rlr (81-99)-pep- 
tide; the Vm,x/K m ratio was 2-fold higher for the former.
The difference in Vmex/K m ratio between phosphotyrosyl 
and phosphoseryl substrates was more pronounced with the 
Mn2+/calmodulin-activated enzyme. The ratio was 20-fold 
higher with phosphoseryl LC2o than with phosphotyrosyl 
LC20, and 59-fold higher with the phosphoseryl Rn-(81-99)- 
peptide than with the phosphotyrosyl [Tyr95]Rn-(81-99)-pep- 
tide. Activation by Ni2+ and calmodulin resulted in higher 
Vmex/K m ratios in comparison to Mn2+ and calmodulin. Except 
in the case of phosphoseryl Rl r (81-99)-peptide, this was 
primarily the result of a marked increase in VmM. In general, 
the enzyme exhibited more favorable kinetic constants for 
phosphotyrosyl substrates in the presence of Ni2+ and cal­
modulin, whereas the enzyme appeared to favor phosphoseryl 
substrates in the presence of Mn2+ and calmodulin.
Nonradioactive phosphoseryl LC2o was found to be an ef­
fective inhibitor of the dephosphorylation of phosphotyrosyl 
LC20. When assayed in the presence of Ni2+ and calmodulin, 
at phosphotyrosyl concentrations of 1 and 2 (see Table I 
for Km values), 1.5-6 tiM of phosphoseryl LC20 caused inhibi­
tion ranging from 30 to 60% (data not shown). Although the 
limited data did not permit rigorous kinetic analysis for the 
exact nature of the inhibition, we nevertheless were able to 
demonstrate a clear competition between the two types of 
substrates. The estimated K, was 2 jtM, assuming competitive 
inhibition.
Brain Versus Cardiac Enzyme—No major differences were 
found between the activities of the enzymes purified from 
brain versus heart. The calmodulin dependence of phospha­
tase activity and the activation by Ni2+ and Mn2+ were very 
similar for both types of enzyme preparations (data not 
shown). The kinetic data shown in Table I for the five 
different substrates were obtained from experiments using a 
single preparation of the brain enzyme. Other preparations of 
brain enzyme occasionally showed specific activities 4-5-fold 
lower than those found with the first preparation. For exam­
ple, using one of the latter preparations, the Km values for 
phosphotyrosyl LC2o were similar to those shown in Table I, 
but the Vm„  values were 4-5-fold lower. (Km = 1.1 nM, Vmax 
= 87 nmol/min/mg in the presence of Ni2+/calmodulin, and 
Km = 5 /tM, Vmax = 2 nmol/min/mg in the presence of Mn2+/  
calmodulin). However, the kinetic constants obtained using 
three separate enzyme preparations from cardiac tissues did 
not vary significantly. For phosphotyrosyl LC20, these values 
(Km = 2 fiM, Vmax = 66 nmol/min/mg with Ni2+/calmodulin; 
and Km = 4.6 /xu, Vrrmt = 8 nmol/min/mg with Mn2+/calmod- 
ulin) were very similar to those found with the second prep­
aration of brain enzyme, which showed lower specific activity. 
It is likely that the variability in specific activity seen with 
different preparations of brain enzyme and the difference in 
specific activities between the most active brain and heart 
preparations are the results of enzyme denaturation occurring 
during purification and handling.
DISCUSSION
The calmodulin-dependent protein phosphatase shows a 
high degree of specificity with substrates containing phospho­
serine and phosphothreonine (4, 8, 14-19), but can also de- 
phosphorylate phosphotyrosine-containing molecules (21­
24). Since the work to date regarding phosphotyrosyl sub­
strates has been rather preliminary, it has been difficult to 
assess the possible importance of the phosphotyrosyl protein 
phosphatase activity of this enzyme. In the present study, we 
used a variety of defined peptide and protein substrates to 
make thorough and direct comparisons of the phosphotyrosyl 
and phosphoseryl phosphatase activities of the calmodulin- 
dependent phosphatase. In addition, with the finding that a 
synthetic phosphoserine-containing peptide based on the 
structure of the autophosphorylation site of Type II regulatory 
subunit of the cyclic AMP-dependent protein kinase is an 
excellent substrate for the phosphatase (19), the opportunity 
presented itself to use a phosphotyrosine analogue of the 
peptide in a comparative study of this type. It was reasoned 
that this approach could provide more meaningful informa­
tion that might be obtained by comparing the action of the 
phosphatase on a randomly selected set of phosphoserine 
(threonine)- and phosphotyrosine-containing proteins.
The five substrates employed in the present study represent 
a diverse array of peptide and polypeptide molecules, with 
differing amino acid sequences and varying chain length. All 
of these substrates are of known sequence and contain phos­
phoserine or phosphotyrosine residues at defined sites (see 
Table II). The two substrates, phosphoseryl LC2o and phos­
photyrosyl LCZ0, have identical overall primary structure. 
They differ in their phosphorylated amino acids and thus also 
the amino acid sequences around the phosphorylation sites. 
In contrast, the two synthetic peptides based on Rn have 
identical sequence around the phosphorylation sites and differ 
only in the phosphorylated amino acids. In a previous paper 
(19), it has been shown that Rh is among the few known 
favored phosphoseryl substrates of the calmodulin-dependent 
protein phosphatase (8,17, 25). The kinetic constants for the 
19-residue peptide Rn-(81-99)-peptide are comparable to 
those of the intact Rn protein (19); (also see Table I). In 
experiments using synthetic peptides with sequences based 
on Rl r (81-99)-peptide in which peptide chain length was 
varied, comparison of kinetic constants indicated that higher 
order structures are important for recognition of phosphoseryl 
protein substrates. Theoretical consideration of the primary 
structure suggests that the N  terminus of RIr(81-99)-peptide 
has a potential to form an amphipathic S-sheet structure. In 
the present study, the [Tyr95]Rn-(81-99)-peptide could pre­
sumably also form the necessary /3-sheet structure. However, 
it was not a particularly good substrate; the Km values were
10-fold lower than that of Rl r (81-99)-peptide, but the Vma, 
values were very much lower (Table I). This peptide was also 
not a significantly better substrate than either of the other 
two phosphotyrosyl substrates examined. Due to lack of ad­
ditional well-characterized phosphotyrosyl substrates, it is at 
present difficult to speculate on the structural determinants 
of substrate specificity, but the data suggest that they differ 
with phosphotyrosyl versus phosphoseryl substrates. Consist­
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photyrosyl and phosphoseryl phosphatase activities of the 
enzyme are differentially activated by Ni2+ versus Mn2+. This 
raises the question of whether the two phosphatase activities 
can be attributed to the same catalytic site of the enzyme; 
however, the results of the substrate competition experiments 
suggest that phosphoseryl LC2o and phosphotyrosyl LC2o in­
teract with the same catalytic site. Additional experiments 
are needed to clarify this point.
Our study offers several lines of evidence against the pos­
sibility that the dephosphorylation of phosphotyrosyl sub­
strates and phosphoseryl substrates is catalyzed by two dif­
ferent enzymes. First, both phosphotyrosyl and phosphoseryl 
phosphatase activities were activated by Ni2+ and Mn2+ and 
were similarly dependent on calmodulin. Second, quite similar 
Km and values were obtained for the two types of sub­
strates with enzyme prepared from two distinct tissues (brain 
and heart) using different purification procedures (7, 19). 
Third, dephosphorylation of phosphotyrosyl LC20 can be in­
hibited by phosphoseryl LC20. Finally, an antibody against 
the brain enzyme causes similar inhibition of the phosphatase 
activity with both phosphotyrosyl and phosphoseryl sub­
strates. Taken together, these data strongly support the view 
that the phosphotyrosyl protein phosphatase activity de­
scribed herein is an integral property of the calmodulin- 
dependent protein phosphatase.
The present study provides quantitative data to serve as a 
basis for comparing the ability of the calmodulin-dependent 
protein phosphatase to act on phosphotyrosine- and phospho- 
serine-containing substrates. However, it is still not possible 
to draw any final conclusions concerning the physiological 
significance of the dephosphorylation of phosphotyrosine- 
containing substrates by this enzyme. Our present results 
clearly indicate that further work in this area is warranted. 
Important in this respect would be the examination of cellular 
proteins identified as natural substrates of protein tyrosine 
kinases as these become available. The finding that both 
phosphotyrosyl and phosphoseryl protein phosphatase activ­
ities reside in the same enzyme protein is intriguing. The 
possible mechanisms by which a protein phosphatase with 
dual activities might regulate the coordinate dephosphoryla­
tion of phosphotyrosine and phosphoserine/threonine resi­
dues on proteins await further investigations.
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